Götz C - Search Results

1

Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery.

Gratz A, Bollacke A, Stephan S, Nienberg C, Le Borgne M, Götz C, Jose J. Gratz A, et al. Among authors: gotz c. Microb Cell Fact. 2015 Jun 3;14:74. doi: 10.1186/s12934-015-0263-z. Microb Cell Fact. 2015. PMID: 26036951 Free PMC article.

2

p21WAF1/CIP1 interacts with protein kinase CK2.

Götz C, Wagner P, Issinger OG, Montenarh M. Götz C, et al. Oncogene. 1996 Jul 18;13(2):391-8. Oncogene. 1996. PMID: 8710378

3

Protein kinase CK2 interacts with a multi-protein binding domain of p53.

Götz C, Scholtes P, Prowald A, Schuster N, Nastainczyk W, Montenarh M. Götz C, et al. Mol Cell Biochem. 1999 Jan;191(1-2):111-20. Mol Cell Biochem. 1999. PMID: 10094399

4

Binding domain for p21(WAF1) on the polypeptide chain of the protein kinase CK2 beta-subunit.

Götz C, Kartarius S, Scholtes P, Montenarh M. Götz C, et al. Biochem Biophys Res Commun. 2000 Feb 24;268(3):882-5. doi: 10.1006/bbrc.2000.2230. Biochem Biophys Res Commun. 2000. PMID: 10679299

5

Wild-type p53 inhibits protein kinase CK2 activity.

Schuster N, Götz C, Faust M, Schneider E, Prowald A, Jungbluth A, Montenarh M. Schuster N, et al. Among authors: gotz c. J Cell Biochem. 2001;81(1):172-83. doi: 10.1002/1097-4644(20010401)81:1<172::aid-jcb1033>3.0.co;2-o. J Cell Biochem. 2001. PMID: 11180407

6

Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes.

Faust M, Günther J, Morgenstern E, Montenarh M, Götz C. Faust M, et al. Among authors: gotz c. Cell Mol Life Sci. 2002 Dec;59(12):2155-64. doi: 10.1007/s000180200022. Cell Mol Life Sci. 2002. PMID: 12568341 Free PMC article.

7

Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention.

Schwindling SL, Noll A, Montenarh M, Götz C. Schwindling SL, et al. Among authors: gotz c. Oncogene. 2004 May 20;23(23):4155-65. doi: 10.1038/sj.onc.1207566. Oncogene. 2004. PMID: 15064744

8

Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Götz C, Kartarius S, Schetting S, Montenarh M. Götz C, et al. Mol Cell Biochem. 2005 Jun;274(1-2):181-7. doi: 10.1007/s11010-005-2950-2. Mol Cell Biochem. 2005. PMID: 16335537

9

Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells.

Götz C, Bachmann C, Montenarh M. Götz C, et al. Prostate. 2007 Feb 1;67(2):125-34. doi: 10.1002/pros.20471. Prostate. 2007. PMID: 17044081

10

Synthesis and biological evaluation of 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives as human protein kinase CK2 and p60(c-Src) tyrosine kinase inhibitors.

Olgen S, Götz C, Jose J. Olgen S, et al. Among authors: gotz c. Biol Pharm Bull. 2007 Apr;30(4):715-8. doi: 10.1248/bpb.30.715. Biol Pharm Bull. 2007. PMID: 17409508 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters